Cargando…
Intrathecal Baclofen in Hereditary Spastic Paraparesis
Introduction: Treatment with intrathecal baclofen (ITB) is a therapeutic option in the management of severe spasticity in patients with hereditary spastic paraparesis (HSP). However, information on the impact of ITB on the natural course of disease, especially the effect of ITB on functional paramet...
Autores principales: | Pucks-Faes, Elke, Dobesberger, Judith, Hitzenberger, Gabriel, Matzak, Heinrich, Mayr, Andreas, Fava, Elena, Genelin, Eleonora, Saltuari, Leopold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716054/ https://www.ncbi.nlm.nih.gov/pubmed/31507512 http://dx.doi.org/10.3389/fneur.2019.00901 |
Ejemplares similares
-
On the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity—An observational study
por: Halbmayer, Lucas‐Michael, et al.
Publicado: (2022) -
Intrathecal baclofen in paroxysmal sympathetic hyperactivity: Impact on oral treatment
por: Pucks‐Faes, Elke, et al.
Publicado: (2018) -
Eleven years’ experience with Intrathecal Baclofen – Complications, risk factors
por: Pucks‐Faes, Elke, et al.
Publicado: (2018) -
Complications After Dual Placement of a Baclofen Pump and Ventricular Shunt in Individuals With Severe Brain Injury
por: Pucks-Faes, Elke, et al.
Publicado: (2020) -
Serotonin Syndrome Mimicking Intrathecal Baclofen Withdrawal in a Patient with Hereditary Spastic Paraparesis
por: Goffin, Nicolas, et al.
Publicado: (2020)